Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of 88 cases investigated in a single clinical center

被引:54
作者
Luton, JP
Martinez, M
Coste, J
Bertherat, T
机构
[1] Hop Cochin, Serv Malad Endocriniennes & Metab, Clin Malad Endocriniennes & Metab, F-75014 Paris, France
[2] Hop Cochin, Dept Biostat, F-75014 Paris, France
[3] Univ Paris 05, Paris, France
关键词
D O I
10.1530/eje.0.1430111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The study was designed to evaluate the clinical, endocrinological and radiological parameters used to investigate adrenal incidentalomas and select patients for surgery. Design and Methods: An analysis of 88 consecutive patients with adrenal incidentaloma selected for surgery and investigated in a single clinical center was performed. Results: Mean (+/-S.D.) age of the patients was 53 +/- 14 years. Fourteen (16%) of the adrenal incidentalomas were malignant tumors (2 adrenocortical carcinomas, 3 metastases, 4 adenocarcinomas, 4 sarcomas and 1 mesenchymoma), 10 (11%) were pheochromocytomas, 32 (36%) were non-secretory benign adrenal adenomas and the remaining were benign adrenal (n = 8: 9%) or extraadrenal (n = 24: 27%) masses. Endocrinological investigations revealed 1 Conn adenoma, 4 tumors responsible for Cushing's syndrome or silent hypercortisolism and 1 androgen secreting tumor. Abnormalities of endocrine evaluations were observed in the 2 malignant adrenocortical carcinomas. Elevated 24-h urinary metanephrine levels were observed in the 9 pheochromocytomas tested. Complications of surgery occurred in 14% of the cases. Regardless of the endocrine status, parameters associated with malignant tumors were: older age (mean age of patients harboring malignant tumors vs patients with benign incidentalomas: 62 +/- 17 years vs 52 +/- 13 years, P = 0.005), weight loss (39% vs 7%, P = 0.005), and mass diameter greater than 60 mm (69% vs 15%, P < 0.001). By multiple logistic regression analysis malignant tumors were associated with increased age, diameter greater than 60 mm and bilateral masses. Conclusion: This study points to a high rate of pheochromocytomas and malignant tumors in patients selected for surgery. This high rate differs from some previous reports and might be explained by the criteria used to select patients for surgery. Among these two groups of tumors, careful systematic endocrinological investigations allow the detection of altered secretion in the vast majority - if not all malignant tumors of adrenal origin and pheochromocytomas. Only 5% of the incidentalomas below 30 mm selected for surgery in this study were malignant, in keeping with the use of this criteria as an important parameter to select patients with normal hormonal investigations for careful follow-up.
引用
收藏
页码:111 / 117
页数:7
相关论文
共 53 条
[1]  
Ambrosi B, 1995, Minerva Endocrinol, V20, P39
[2]   Adrenal incidentaloma: An overview of clinical and epidemiological data from the National Italian Study Group [J].
Angeli, A ;
Osella, G ;
Ali, A ;
Terzolo, M .
HORMONE RESEARCH, 1997, 47 (4-6) :279-283
[3]   A SURVEY ON INCIDENTAL ADRENAL-TUMORS IN JAPAN [J].
ASO, Y ;
HOMMA, Y .
JOURNAL OF UROLOGY, 1992, 147 (06) :1478-1481
[4]   Overnight dexamethasone suppression test: Comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome [J].
Barrou, Z ;
Guiban, D ;
Maroufi, A ;
Fournier, C ;
Dugue, MA ;
Luton, JP ;
Thomopoulos, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (01) :93-96
[5]  
BATHIA V, 1994, ARCH PEDIAT ADOL MED, V148, P994
[6]   DIFFERENTIATION BETWEEN SMALL BENIGN AND MALIGNANT ADRENAL MASSES WITH DYNAMIC INCREMENTED CT [J].
BERLAND, LL ;
KOSLIN, DB ;
KENNEY, PJ ;
STANLEY, RJ ;
LEE, JY .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 151 (01) :95-101
[7]  
BEYER HS, 1985, J CLIN ENDOCR METAB, V62, P1317
[8]   INDETERMINATE ADRENAL MASS IN PATIENTS WITH CANCER - EVALUATION AT PET WITH 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE [J].
BOLAND, GW ;
GOLDBERG, MA ;
LEE, MJ ;
MAYOSMITH, WW ;
DIXON, J ;
MCNICHOLAS, MM ;
MUELLER, PR .
RADIOLOGY, 1995, 194 (01) :131-134
[9]  
CANDEL AG, 1993, SURGERY, V114, P1132
[10]  
CAPLAN RH, 1994, ARCH SURG-CHICAGO, V129, P291